Portfolio
IsoTis
- Country:
- USA
- Activity:
- Bone graft substitutes
- Entry:
- 1997
- Exit Mode:
- IPO AEX - 2000
- Website:
- www.isotis.com
Description
IsoTis manufactures, markets and sells a range of innovative bone graft substitutes and other related medical devices that are used to enhance the repair and regeneration of bone in spinal and trauma surgery, total joint replacements and dental applications. IsoTis products have been used safely and effectively in more than 250,000 patients to date. IsoTis’ main commercial operations are based in Irvine, California, and its international sales headquarters are based in Lausanne, Switzerland. In 2007 Integra LifeSciences acquired IsoTis.